| NCT00000406 |
|
Effects of Strength Training on Knee Osteoarthritis
|
View
|
| NCT00000405 |
|
Effects of Jumping on Growing Bones
|
View
|
| NCT00000404 |
|
Effects of Comprehensive Care for Knee OA
|
View
|
| NCT00000403 |
|
Doxycycline and OA Progression
|
View
|
| NCT00000402 |
|
Calcium and Bone Mass in Young Females
|
View
|
| NCT00000401 |
|
Oral Collagen for Rheumatoid Arthritis
|
View
|
| NCT00000400 |
|
Alendronate andor Parathyroid Hormone for Osteoporosis
|
View
|
| NCT00000399 |
|
Bone Estrogen Strength Training
|
View
|
| NCT00000398 |
|
Behavioral Treatment of Fibromyalgia
|
View
|
| NCT00000397 |
|
Behavioral Insomnia Therapy for Fibromyalgia
|
View
|
| NCT00000396 |
|
Arthritis Patient Education for Urban African Americans
|
View
|
| NCT00000395 |
|
Antifolate Effectiveness in Arthritis
|
View
|
| NCT00000394 |
|
Acupuncture for Carpal Tunnel Syndrome
|
View
|
| NCT00000393 |
|
A Phase I Trial of Peptide T Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome AIDS
|
View
|
| NCT00000392 |
|
Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment
|
View
|
| NCT00000391 |
|
A Phase I Trial of Intranasal Peptide T Safety Toxicity and Pharmacokinetics in Human Immunodeficiency Virus-1 HIV-1 Infected Patients
|
View
|
| NCT00000390 |
|
Antidepressant Treatment of AIDS Related Depression
|
View
|
| NCT00000389 |
|
Treatment for Anxiety in Children
|
View
|
| NCT00000388 |
|
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder MTA
|
View
|
| NCT00000387 |
|
Self-Management Therapy for Youth With Schizophrenia
|
View
|
| NCT00000386 |
|
Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder OCD
|
View
|
| NCT00000385 |
|
Long-Term Lithium Treatment for Aggressive Conduct Disorder
|
View
|
| NCT00000384 |
|
Treatment of Obsessive-Compulsive Disorder OCD in Children
|
View
|
| NCT00000383 |
|
Treatment of Post-Traumatic Stress Disorder PTSD in Sexually Abused Children
|
View
|
| NCT00000382 |
|
Preventing Child Abuse in Infants
|
View
|
| NCT00000381 |
|
Fluoxetine for Anxious Children
|
View
|
| NCT00000380 |
|
Growth Hormone Releasing Hormone GHRH Treatment for Age-Related Sleep Disturbances
|
View
|
| NCT00000379 |
|
Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder PTSD
|
View
|
| NCT00000378 |
|
Antidepressant Treatment of Melancholia in Late Life
|
View
|
| NCT00000377 |
|
Preventing the Return of Depression in Elderly Patients
|
View
|
| NCT00000376 |
|
Cognitive and Drug Therapy for Drug-Resistant Depression
|
View
|
| NCT00000375 |
|
Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
|
View
|
| NCT00000374 |
|
Treatment for First-Episode Schizophrenia
|
View
|
| NCT00000373 |
|
Treatment of Obsessive-Compulsive Disorder
|
View
|
| NCT00000372 |
|
Glycine and D-Cycloserine in Schizophrenia
|
View
|
| NCT00000371 |
|
Trial of D-Cycloserine in Schizophrenia
|
View
|
| NCT00000370 |
|
Treatment of Social Phobia
|
View
|
| NCT00000369 |
|
Maintenance Therapies in Bipolar Disorders
|
View
|
| NCT00000368 |
|
Treatment of Panic Disorder Long Term Strategies
|
View
|
| NCT00000367 |
|
Prevention of Suicide in the Elderly
|
View
|
| NCT00000363 |
|
Acute Otitis Media Adjuvant Therapy to Improve Outcome
|
View
|
| NCT00000362 |
|
Randomized Study of Two Interventions for Liquid Aspiration Short-Term and Long-Term Effects
|
View
|
| NCT00000361 |
|
Autoimmunity in Inner Ear Disease
|
View
|
| NCT00000359 |
|
Treatments for Benign Paroxysmal Positional Vertigo BPPV
|
View
|
| NCT00000358 |
|
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
|
View
|
| NCT00000357 |
|
Buprenorphine Maintenance for Opiate Dependence - 6
|
View
|
| NCT00000356 |
|
Evaluation of L-alpha-acetylmethadol LAAM in Methadone Patients - 5
|
View
|
| NCT00000355 |
|
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
|
View
|
| NCT00000354 |
|
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
|
View
|
| NCT00000353 |
|
Trial of BuprenorphineNaloxone for Opiate Dependence - 2
|
View
|
| NCT00000352 |
|
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
|
View
|
| NCT00000351 |
|
Cognitive Correlates of Substance Abuse Part 2 - 16
|
View
|
| NCT00000350 |
|
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
|
View
|
| NCT00000349 |
|
Infusion Laboratory Protocol 5 Flupenthixol - 14
|
View
|
| NCT00000348 |
|
Infusion Laboratory Protocol 4 Dihydrexidine - 13
|
View
|
| NCT00000347 |
|
Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
|
View
|
| NCT00000346 |
|
Cognitive Correlates of Substance Abuse - 11
|
View
|
| NCT00000345 |
|
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
|
View
|
| NCT00000344 |
|
BuprenorphineNaloxone for Treatment of Opiate Dependence - 9
|
View
|
| NCT00000343 |
|
Brain Changes in Stimulant Dependent Subjects - 8
|
View
|
| NCT00000342 |
|
Risperidone for the Treatment of Cocaine Dependence - 7
|
View
|
| NCT00000341 |
|
Evaluation of Liquid vs Tablet Buprenorphine - 6
|
View
|
| NCT00000340 |
|
Pemoline in the Treatment of Stimulant Dependence - 5
|
View
|
| NCT00000339 |
|
Infusion Laboratory Protocol 3 Risperidone - 4
|
View
|
| NCT00000338 |
|
Infusion Laboratory Protocol 2 Lisuride - 3
|
View
|
| NCT00000337 |
|
Infusion Laboratory Protocol 1 - Selegeline - 2
|
View
|
| NCT00000336 |
|
Selegiline in Outpatient Treatment for Cocaine Dependence - 1
|
View
|
| NCT00000335 |
|
Activity Monitoring Assessment of Opiate Withdrawal - 4
|
View
|
| NCT00000334 |
|
Comparison of Buprenorphine and Methadone - 3
|
View
|
| NCT00000333 |
|
Evaluation of Benztropine for Cocaine Craving - 2
|
View
|
| NCT00000332 |
|
High Dose Nimodipine Treatment Adjunct - 1
|
View
|
| NCT00000331 |
|
BuprenorphineNaloxone Treatment for Opioid Dependence-Experiment II-3 - 6
|
View
|
| NCT00000330 |
|
BuprenorphineNaloxone Treatment for Opioid Dependence-Experiment II-2 - 5
|
View
|
| NCT00000329 |
|
BuprenorphineNaloxone Treatment for Opioid Dependence-Experiment II-1 - 4
|
View
|
| NCT00000328 |
|
BuprenorphineNaloxone Treatment for Opioid Dependence-Experiment III - 3
|
View
|
| NCT00000327 |
|
BuprenorphineNaloxone Treatment for Opioid Dependence-Experiment I2 - 2
|
View
|
| NCT00000326 |
|
BuprenorphineNaloxone Treatment for Opioid Dependence-Experiment 1 - 1
|
View
|
| NCT00000325 |
|
Psychostimulant Abuse - Novel Treatment Approaches - 1
|
View
|
| NCT00000324 |
|
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
|
View
|
| NCT00000323 |
|
Therapeutic Potential of Kappa-Opioids Against Cocaine - 1
|
View
|
| NCT00000322 |
|
Tyrosine for Methamphetamine Dependence - 1
|
View
|
| NCT00000321 |
|
Methamphetamine Abuse Treatment in Patients With AIDS - 1
|
View
|
| NCT00000320 |
|
Buprenorphine Formulation Comparison Sublingual Tablet vs Solution - 1
|
View
|
| NCT00000319 |
|
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
|
View
|
| NCT00000318 |
|
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
|
View
|
| NCT00000317 |
|
Early Phase II Trials for Cocaine Medication Development - 1
|
View
|
| NCT00000316 |
|
Human Dopamine Transported Imaging in Cocaine Abuse 2 - 2
|
View
|
| NCT00000315 |
|
Human Dopamine Transported Imaging in Cocaine Abuse 1 - 1
|
View
|
| NCT00000314 |
|
M-CPP and Fenfluramine in Cocaine Addicts - 3
|
View
|
| NCT00000313 |
|
Predictive Values of Serotonergic Alterations for Outcome - 2
|
View
|
| NCT00000312 |
|
Alterations in Serotonergic Functions in Cocaine Addicts - 1
|
View
|
| NCT00000311 |
|
Combining Behavioral Treatment With Agonist Maintenance - 1
|
View
|
| NCT00000310 |
|
SerotoninDopamine Antagonism of Cocaine Effect 2 - 2
|
View
|
| NCT00000309 |
|
SerotoninDopamine Antagonism of Cocaine Effect 1 - 1
|
View
|
| NCT00000308 |
|
Dextroamphetamine-Cocaine Behavioral Intervention - 5
|
View
|
| NCT00000307 |
|
Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
|
View
|
| NCT00000306 |
|
Dextroamphetamine as Adjunct in CocaineOpiate Dependent Patients - 3
|
View
|
| NCT00000305 |
|
Amphetamine Cocaine Interaction Study - 2
|
View
|
| NCT00000304 |
|
Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
|
View
|
| NCT00000303 |
|
Rapid Evaluation of Baclofen for Treatment of Cocaine AbuseDependence - 6
|
View
|
| NCT00000302 |
|
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
|
View
|
| NCT00000301 |
|
Rapid Evaluation of Amantadine for Treatment of Cocaine AbuseDependence - 4
|
View
|
| NCT00000300 |
|
Feasibility Study of Take-Home LAAM Medication - 3
|
View
|
| NCT00000299 |
|
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
|
View
|
| NCT00000298 |
|
Buprenorphine Combination Tablet Feasibility - 1
|
View
|
| NCT00000297 |
|
Effects of Labetalol on Nicotine Administration in Humans - 14
|
View
|
| NCT00000296 |
|
Role of Metabolites in Nicotine Dependence 4 - 13
|
View
|
| NCT00000295 |
|
Progesterone Treatment in Female Smokers - 12
|
View
|
| NCT00000294 |
|
Effects of Carvedilol on Cocaine Use in Humans - 11
|
View
|
| NCT00000293 |
|
Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
|
View
|
| NCT00000292 |
|
Acute Withdrawal From Smoked Cocaine - 9
|
View
|
| NCT00000291 |
|
Effects of Labetalol on Human Cocaine Use - 8
|
View
|
| NCT00000290 |
|
Stress Hormones and Human Cocaine Use - 7
|
View
|
| NCT00000289 |
|
Role of Metabolites in Nicotine Dependence 3 - 6
|
View
|
| NCT00000288 |
|
Role of Metabolites in Nicotine Dependence 2 - 5
|
View
|
| NCT00000287 |
|
Relapse Patterns in Female Cocaine Users - 4
|
View
|
| NCT00000286 |
|
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
|
View
|
| NCT00000285 |
|
Effects of Phenytoin on Cocaine Use in Humans - 2
|
View
|
| NCT00000284 |
|
Role of Metabolites in Nicotine Dependence 1 - 1
|
View
|
| NCT00000282 |
|
Pemoline for Cocaine Abuse - 7
|
View
|
| NCT00000281 |
|
Pharmacotherapy for Schizophrenic Drug Users - 6
|
View
|
| NCT00000280 |
|
Glutaminergic Agents for Cocaine Abuse - 5
|
View
|
| NCT00000279 |
|
Novel Medications for Opiate Detoxification - 4
|
View
|
| NCT00000278 |
|
Disulfiram for Cocaine-Alcohol Abuse - 3
|
View
|
| NCT00000277 |
|
Mazindol for Cocaine Abuse - 2
|
View
|
| NCT00000276 |
|
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
|
View
|
| NCT00000275 |
|
Cocaine Abuse and ADHD - 10
|
View
|
| NCT00000274 |
|
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
|
View
|
| NCT00000273 |
|
A Laboratory Model for Heroin Abuse Medications - 8
|
View
|
| NCT00000271 |
|
New Approaches to Cocaine Abuse Medications A - 6
|
View
|
| NCT00000270 |
|
Brain Imaging Cocaine Effects Medication Development - 5
|
View
|
| NCT00000269 |
|
Pergolide Treatment for Substance Abusers - 4
|
View
|
| NCT00000268 |
|
Cocaine Abuse and Attention Deficit Disorder - 3
|
View
|
| NCT00000267 |
|
Risperidone Treatment in Dually-Diagnosed Individuals - 2
|
View
|
| NCT00000266 |
|
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
|
View
|
| NCT00000265 |
|
Subjective Effects of Nitrous Oxide in Dental Patients - 17
|
View
|
| NCT00000264 |
|
SubjectivePsychomotor Effects of Combined Alcohol Nitrous Oxide - 16
|
View
|
| NCT00000263 |
|
Effects of Combined Alcohol and Nitrous Oxide Intake - 15
|
View
|
| NCT00000262 |
|
Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
|
View
|
| NCT00000261 |
|
Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
|
View
|
| NCT00000260 |
|
Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
|
View
|
| NCT00000259 |
|
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
|
View
|
| NCT00000258 |
|
Role of Instructions in Nitrous Oxide Effects and Choice - 10
|
View
|
| NCT00000257 |
|
Effects of Alcohol History on Effects of Nitrous Oxide - 9
|
View
|
| NCT00000256 |
|
Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
|
View
|
| NCT00000255 |
|
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
|
View
|
| NCT00000254 |
|
Isoflurane at Subanesthetic Concentrations - 6
|
View
|
| NCT00000253 |
|
Effects of Nitrous Oxide A Dose-Response Analysis - 5
|
View
|
| NCT00000252 |
|
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
|
View
|
| NCT00000251 |
|
Effects of Subanesthetic Concentrations of IsofluraneNitrous Oxide - 3
|
View
|
| NCT00000250 |
|
Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
|
View
|
| NCT00000249 |
|
Effects of Subanesthetic Concentrations of Nitrous Oxide - 1
|
View
|
| NCT00000248 |
|
Dose Response Trial of Pergolide for Cocaine Dependence - 1
|
View
|
| NCT00000246 |
|
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
|
View
|
| NCT00000245 |
|
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
|
View
|
| NCT00000244 |
|
Effects of Dynorphin 1-13 on Heroin Addiction - 1
|
View
|
| NCT00000243 |
|
Effects of BuprenorphineNaloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
|
View
|
| NCT00000242 |
|
Carbamazepine Treatment of Cocaine Dependence - 1
|
View
|
| NCT00000241 |
|
Flupenthixol Decanoate in Methamphetamine Smoking - 1
|
View
|
| NCT00000240 |
|
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence - 22
|
View
|
| NCT00000239 |
|
Buprenorphine Pharmacology Related to Addiction Treatment - 21
|
View
|
| NCT00000238 |
|
Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
|
View
|
| NCT00000237 |
|
Buprenorphine Detoxification - BBDVI - 19
|
View
|
| NCT00000236 |
|
Buprenorphine Pharmacology Related to Addiction Treatment - 18
|
View
|
| NCT00000235 |
|
Alternate Day Buprenorphine Administration Phase XII - 17
|
View
|
| NCT00000234 |
|
Alternate Day Buprenorphine Administration Phase XI - 16
|
View
|
| NCT00000233 |
|
Alternate Day Buprenorphine Administration Phase X - 15
|
View
|
| NCT00000232 |
|
Alternate Day Buprenorphine Administration Phase IX - 14
|
View
|
| NCT00000231 |
|
Buprenorphine Detoxification With Two Types of Treatment BBD IV - 13
|
View
|
| NCT00000230 |
|
Buprenorphine Detoxification With Two Types of Treatment BBD III - 12
|
View
|
| NCT00000229 |
|
Buprenorphine Detox With Two Types of Treatment BBD II - 11
|
View
|
| NCT00000228 |
|
Buprenorphine Detox With Two Types of Treatment BBD I - 10
|
View
|
| NCT00000227 |
|
Alternate-Day Buprenorphine Administration Phase VIII - 9
|
View
|
| NCT00000226 |
|
Alternate-Day Buprenorphine Administration Phase VII - 8
|
View
|
| NCT00000225 |
|
Alternate-Day Buprenorphine Administration Phase VI - 7
|
View
|
| NCT00000224 |
|
Alternate-Day Buprenorphine Phase V - 6
|
View
|
| NCT00000223 |
|
Alternate-Day Buprenorphine Administration Phase IV - 5
|
View
|
| NCT00000222 |
|
Alternate-Day Buprenorphine Administration Phase II - 4
|
View
|
| NCT00000221 |
|
Alternate-Day Buprenorphine Administration Phase I - 3
|
View
|
| NCT00000220 |
|
Gradual Vs Rapid Buprenorphine Detoxification - 2
|
View
|
| NCT00000219 |
|
Buprenorphine Dose Alteration Study - 1
|
View
|
| NCT00000218 |
|
Pharmacotherapy and Intensive Treatment - 2
|
View
|
| NCT00000217 |
|
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
|
View
|
| NCT00000216 |
|
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
|
View
|
| NCT00000215 |
|
IV Cocaine Abuse A Laboratory Model - 4
|
View
|
| NCT00000214 |
|
IV Cocaine Abuse A Laboratory Model - 3
|
View
|
| NCT00000213 |
|
IV Cocaine Abuse A Laboratory Model - 2
|
View
|
| NCT00000212 |
|
IV Cocaine Abuse A Laboratory Model - 1
|
View
|
| NCT00000211 |
|
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
|
View
|
| NCT00000210 |
|
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
|
View
|
| NCT00000209 |
|
Buprenorphine Dosing Interval - 5
|
View
|
| NCT00000208 |
|
MethadoneBuprenorphine Cross-Over Study - 4
|
View
|
| NCT00000207 |
|
Multicenter Clinical Trial of Buprenorphine - 3
|
View
|
| NCT00000206 |
|
Clinical Rescue Protocol - 2
|
View
|
| NCT00000205 |
|
Buprenorphine Maintenance Protocol - 1
|
View
|
| NCT00000204 |
|
Buprenorphine Maintenance for Opioid Addicts - 3
|
View
|
| NCT00000203 |
|
Buprenorphine Maintenance for Opioid Addicts - 2
|
View
|
| NCT00000202 |
|
Buprenorphine Maintenance for Opioid Addicts - 1
|
View
|
| NCT00000201 |
|
Pharmacological Modulation of Cocaine Effects - 1
|
View
|
| NCT00000200 |
|
Cocaine Effects in Humans Physiology and Behavior - 1
|
View
|
